InMed Pharmaceuticals Inc. (INM)
USD 3.09
(-0.16%)
USD 3.09
(-0.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -6.98 Billion USD | -21.53% |
| 2023 | 1.4 Million USD | 158.13% |
| 2022 | 543.54 Thousand USD | 375.87% |
| 2021 | -197.03 Thousand USD | -7.61% |
| 2020 | -183.09 Thousand CAD | -94.9% |
| 2019 | -93.94 Thousand CAD | -1.25% |
| 2018 | -92.77 Thousand USD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | -100.0% |
| 2011 | 39.65 Thousand CAD | -43.91% |
| 2010 | 70.7 Thousand CAD | 18.77% |
| 2009 | 59.53 Thousand CAD | -72.67% |
| 2008 | 217.79 Thousand CAD | 370.37% |
| 2007 | -80.55 Thousand CAD | -106.0% |
| 2006 | 1.34 Million CAD | 28.86% |
| 2005 | 1.04 Million CAD | 16.71% |
| 2004 | 892.2 Thousand CAD | 833.31% |
| 2003 | 95.59 Thousand CAD | 2916.59% |
| 2002 | -3394.00 CAD | 76.72% |
| 2001 | -14.58 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 139.07 Thousand USD | -57.09% |
| 2024 Q4 | 1.1 Billion USD | -5025217.95% |
| 2024 Q1 | 21.24 Thousand USD | -98.65% |
| 2024 Q2 | 324.14 Thousand USD | 1425.95% |
| 2023 Q1 | -491.01 Thousand USD | -566.79% |
| 2023 Q2 | 131.16 Thousand USD | 126.71% |
| 2023 Q4 | 1.57 Million USD | 715.74% |
| 2023 Q3 | 192.51 Thousand USD | 46.77% |
| 2023 FY | 1.4 Million USD | 158.13% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q4 | 105.19 Thousand USD | 166.39% |
| 2022 FY | 543.54 Thousand USD | 375.87% |
| 2022 Q3 | 39.48 Thousand USD | -64.6% |
| 2022 Q2 | 111.55 Thousand USD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | -197.03 Thousand USD | -7.61% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 FY | -183.09 Thousand CAD | -94.9% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | -93.94 Thousand CAD | -1.25% |
| 2019 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | -92.77 Thousand USD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | -100.0% |
| 2012 FY | - CAD | -100.0% |
| 2011 FY | 39.65 Thousand CAD | -43.91% |
| 2011 Q3 | 16.66 Thousand CAD | 948.47% |
| 2011 Q4 | 138.33 CAD | -99.17% |
| 2011 Q2 | 1589.75 CAD | 127.9% |
| 2011 Q1 | -5698.78 CAD | -111.07% |
| 2010 Q3 | 3434.37 CAD | 2040.55% |
| 2010 Q4 | 51.46 Thousand CAD | 1398.56% |
| 2010 Q1 | 14.91 Thousand CAD | -16.25% |
| 2010 Q2 | 160.44 CAD | -98.92% |
| 2010 FY | 70.7 Thousand CAD | 18.77% |
| 2009 Q1 | 41.58 Thousand CAD | 133.85% |
| 2009 Q3 | 6612.81 CAD | 2471.18% |
| 2009 Q2 | 257.19 CAD | -99.38% |
| 2009 Q4 | 17.81 Thousand CAD | 169.37% |
| 2009 FY | 59.53 Thousand CAD | -72.67% |
| 2008 Q1 | -398.87 CAD | 98.81% |
| 2008 Q4 | -122.84 Thousand CAD | -177.32% |
| 2008 Q3 | 158.88 Thousand CAD | -20.55% |
| 2008 Q2 | 199.97 Thousand CAD | 50234.64% |
| 2008 FY | 217.79 Thousand CAD | 370.37% |
| 2007 Q2 | -295.46 Thousand CAD | -248.7% |
| 2007 Q4 | -33.48 Thousand CAD | -156.62% |
| 2007 Q1 | 198.69 Thousand CAD | -32.58% |
| 2007 Q3 | 59.14 Thousand CAD | 120.02% |
| 2007 FY | -80.55 Thousand CAD | -106.0% |
| 2006 Q1 | 308.95 Thousand CAD | 35.22% |
| 2006 Q3 | 232.53 Thousand CAD | -48.2% |
| 2006 Q2 | 448.9 Thousand CAD | 45.3% |
| 2006 Q4 | 294.71 Thousand CAD | 26.74% |
| 2006 FY | 1.34 Million CAD | 28.86% |
| 2005 FY | 1.04 Million CAD | 16.71% |
| 2005 Q4 | 228.47 Thousand CAD | -26.28% |
| 2005 Q3 | 309.94 Thousand CAD | -5.48% |
| 2005 Q2 | 327.9 Thousand CAD | 93.11% |
| 2005 Q1 | 169.8 Thousand CAD | -59.93% |
| 2004 Q1 | 226.78 Thousand CAD | 186.45% |
| 2004 FY | 892.2 Thousand CAD | 833.31% |
| 2004 Q4 | 423.79 Thousand CAD | 269.01% |
| 2004 Q3 | 114.84 Thousand CAD | -25.42% |
| 2004 Q2 | 154 Thousand CAD | -32.1% |
| 2003 Q1 | 7878.21 CAD | 715.99% |
| 2003 FY | 95.59 Thousand CAD | 2916.59% |
| 2003 Q4 | 79.17 Thousand CAD | 712.22% |
| 2003 Q2 | -1782.98 CAD | -122.63% |
| 2003 Q3 | 9747.55 CAD | 646.7% |
| 2002 Q1 | -4700.03 CAD | 0.0% |
| 2002 Q2 | 235.21 CAD | 105.0% |
| 2002 FY | -3394.00 CAD | 76.72% |
| 2002 Q4 | 965.48 CAD | 510.53% |
| 2002 Q3 | 158.14 CAD | -32.77% |
| 2001 FY | -14.58 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -15319.826% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -6485.788% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 33284.731% |
| Autolus Therapeutics plc | -4.86 Million USD | -143500.499% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -193494813.344% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -836910.332% |
| Shattuck Labs, Inc. | -2.38 Million USD | -292941.353% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -290262.953% |
| CervoMed Inc. | -1.29 Million USD | -540166.728% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -98364.867% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -22324.001% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -1472686.832% |
| Precision BioSciences, Inc. | 40.47 Million USD | 17368.819% |
| Dyadic International, Inc. | 922.95 Thousand USD | 757343.975% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -10315.23% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -4754346.442% |
| Nektar Therapeutics | 53.47 Million USD | 13168.993% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 7156.853% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 1648457.611% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 16987.441% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -1636676.644% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 7478.394% |
| GRI Bio, Inc. | 10.84 Million USD | 64568.557% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 275260.425% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -80353.969% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -7205092.031% |
| Psyence Biomedical Ltd. | -240.00 USD | -2912098345.833% |
| IGM Biosciences, Inc. | -211.66 Million USD | -3202.011% |
| INmune Bio, Inc. | 155 Thousand USD | 4509155.658% |
| Opthea Limited | 21.72 Thousand USD | 32177983.379% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 1738666.236% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -11033.471% |
| Verastem, Inc. | -62 Thousand USD | -11272539.145% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 287124.077% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -2677691.674% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 230989.867% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 5936.21% |
| NextCure, Inc. | -3.68 Million USD | -189613.254% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -52221.574% |
| Organovo Holdings, Inc. | -5.38 Million USD | -129590.783% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Arvinas, Inc. | 71.8 Million USD | 9834.034% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -579960.775% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 34954.559% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -850147.721% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 115308.522% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 4615.144% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -7015.913% |
| Senti Biosciences, Inc. | -2.68 Million USD | -260393.338% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 4793677.689% |
| Apollomics, Inc. | 127 Thousand USD | 5503278.165% |
| PureTech Health plc | -1.6 Million USD | -435897.272% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -24026.748% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 871550.906% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -6225.549% |
| Synaptogenix, Inc. | -6347.00 USD | -110115486.419% |
| ChromaDex Corporation | 50.78 Million USD | 13863.364% |
| Beam Therapeutics Inc. | -59.67 Million USD | -11612.422% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 5901.282% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -6131.254% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 2167.267% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -111545.947% |
| Mesoblast Limited | -9.81 Million USD | -71107.705% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 5266.769% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -7019.828% |
| MediWound Ltd. | 3.57 Million USD | 195433.602% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 5824296.892% |
| Fortress Biotech, Inc. | 57.85 Million USD | 12180.681% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 16253672.721% |
| Achilles Therapeutics plc | -4.73 Million USD | -147620.183% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 5663.589% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -15980.428% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -30387014.217% |
| Zai Lab Limited | 170.9 Million USD | 4189.475% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 87397.48% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 5376281.746% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 4029.869% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 44183.741% |
| FibroGen, Inc. | 128.9 Million USD | 5521.892% |
| Celcuity Inc. | -142.77 Thousand USD | -4895142.954% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| ContextLogic Inc. | 59 Million USD | 11945.824% |
| GH Research PLC | -315 Thousand USD | -2218641.673% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 42261.044% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 1796767.422% |
| ImmuCell Corporation | 4.39 Million USD | 159075.996% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 2066.831% |
| Amarin Corporation plc | 165.54 Million USD | 4321.937% |
| TG Therapeutics, Inc. | 219.1 Million USD | 3289.768% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -1232534.263% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -630679.447% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -9152.835% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 9621.459% |
| Aptorum Group Limited | -1.11 Million USD | -626894.843% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 1896.483% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 2238.949% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -10458301.948% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 3003.207% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -1352409.022% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -196718.819% |
| Ardelyx, Inc. | 106.66 Million USD | 6652.57% |
| Ainos, Inc. | -253.73 Thousand USD | -2754384.545% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -14939.565% |
| Prothena Corporation plc | -129.2 Million USD | -5309.429% |
| HilleVax, Inc. | -2.15 Million USD | -324066.803% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 13960.551% |
| Celularity Inc. | 6.75 Million USD | 103564.638% |
| Rallybio Corporation | -150 Thousand USD | -4659257.513% |
| Cue Biopharma, Inc. | -32.6 Million USD | -21334.159% |
| Omeros Corporation | -69.77 Million USD | -9915.959% |
| Humacyte, Inc. | -76.55 Million USD | -9030.028% |
| Immunocore Holdings plc | 248.39 Million USD | 2913.724% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -45974.469% |
| Blueprint Medicines Corporation | 236.58 Million USD | 3054.146% |
| IO Biotech, Inc. | -756 Thousand USD | -924375.697% |
| MEI Pharma, Inc. | 49.32 Million USD | 14268.784% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -490014.745% |
| Summit Therapeutics Inc. | -2.05 Million USD | -340828.599% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -145565.616% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 24154.504% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -245646.704% |
| Pulmatrix, Inc. | -8.22 Million USD | -84924.772% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -597253.527% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -350052.118% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -1751538.163% |
| Acelyrin, Inc. | -115 Thousand USD | -6077322.843% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | -1652.543% |
| Cytokinetics, Incorporated | -322.59 Million USD | -2066.518% |
| Vor Biopharma Inc. | -3.49 Million USD | -200044.223% |
| Evogene Ltd. | 1.39 Million USD | 499673.715% |
| Replimune Group, Inc. | -2.65 Million USD | -263140.537% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -15816.005% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -12191638.949% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 102025.569% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | 630879.447% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -21178797.788% |
| Atai Life Sciences N.V. | -5000.00 USD | -139780625.4% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -7280146.115% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 1409179.893% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -503070.358% |
| Sagimet Biosciences Inc. | 2 Million USD | 349551.814% |
| MediciNova, Inc. | 979.7 Thousand USD | 713481.709% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -8188.804% |
| MiMedx Group, Inc. | 266.84 Million USD | 2719.157% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -7391403.643% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 2958.092% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 901.186% |
| Mereo BioPharma Group plc | 7.42 Million USD | 94215.759% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -58241868.917% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -139780625.4% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -283891.722% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Allakos Inc. | -6.14 Million USD | -113709.417% |
| scPharmaceuticals Inc. | 9.78 Million USD | 71547.928% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -10029.625% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 1568.612% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -61264243.18% |
| Precigen, Inc. | 106 Thousand USD | 6593530.443% |
| XOMA Corporation | 3.86 Million USD | 181116.22% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -9872.228% |
| Incyte Corporation | 3.44 Billion USD | 303.131% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -13774114.17% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 47342.37% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 56191.784% |
| Seer, Inc. | 7.02 Million USD | 99559.745% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 3000.545% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -24100025.069% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 53761817561.538% |
| Akari Therapeutics, Plc | -4000.00 USD | -174725806.75% |
| Novavax, Inc. | 639.93 Million USD | 1192.144% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 3589596.205% |
| UroGen Pharma Ltd. | 73.35 Million USD | 9628.079% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -26082.049% |
| Entera Bio Ltd. | -56 Thousand USD | -12480321.911% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -3697802.788% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 172626.198% |
| Chimerix, Inc. | 324 Thousand USD | 2157209.96% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -1331145.004% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 1357194.421% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -15816493.351% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 305.643% |
| AnaptysBio, Inc. | 14.78 Million USD | 47383.92% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 1213097.397% |
| Portage Biotech Inc. | -54 Thousand USD | -12942559.759% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -1853755.775% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -555909.25% |
| OKYO Pharma Limited | -7506.16 USD | -93110575.365% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -155484577.864% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -352981529.798% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -3148214436.036% |
| AbCellera Biologics Inc. | 38.02 Million USD | 18480.109% |
| Genprex, Inc. | -15 Thousand USD | -46581053.492% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -1046162.915% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -61264243.18% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| Daré Bioscience, Inc. | 2.76 Million USD | 252455.326% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -404124.191% |
| Bicycle Therapeutics plc | -129.52 Million USD | -5296.106% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | -1648.728% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 12428.952% |
| Erasca, Inc. | -3.73 Million USD | -187173.212% |
| bluebird bio, Inc. | -4.03 Million USD | -173325.218% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 692769.601% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 467.0% |
| DBV Technologies S.A. | 15.72 Million USD | 44536.904% |
| Fortress Biotech, Inc. | 57.85 Million USD | 12180.681% |
| Avidity Biosciences, Inc. | -181.4 Million USD | -3752.662% |
| CorMedix Inc. | -205.56 Thousand USD | -3399865.105% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 5323.963% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -1223899.347% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 271624.331% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -17664.37% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -6189.177% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 28683.846% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -194689.194% |
| Onconetix, Inc. | -1.12 Million USD | -619954.408% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 36801.34% |
| Prime Medicine, Inc. | -147.9 Million USD | -4625.355% |
| Adagene Inc. | 18.11 Million USD | 38688.961% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 1147725.003% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -4877072.016% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 5084.976% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -3935.52% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 4528.037% |
| SciSparc Ltd. | 2.19 Million USD | 318362.125% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -27901358.222% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -22558276.703% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 7352.445% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 12895.98% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -98258.776% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 560.445% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 7210.773% |
| ADMA Biologics, Inc. | 88.21 Million USD | 8022.461% |
| Clene Inc. | 533 Thousand USD | 1311363.841% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 29089.103% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -730206.82% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 351661.181% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -3596637.412% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 14132.8% |
| Absci Corporation | -41.84 Million USD | -16600.605% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 161.842% |
| Surrozen, Inc. | -27.23 Million USD | -25566.677% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -8906.722% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -14821.404% |
| Cingulate Inc. | -582.91 Thousand USD | -1198874.173% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -22545178.29% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -92325346.103% |
| Jaguar Health, Inc. | 7.72 Million USD | 90584.675% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -793207.182% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 1126.733% |
| Kronos Bio, Inc. | 1.37 Million USD | 509504.976% |
| Innoviva, Inc. | 261.06 Million USD | 2777.125% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -12923.211% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 24093.396% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -67202171.827% |
| Soligenix, Inc. | 97.31 Thousand USD | 7182264.678% |
| AlloVir, Inc. | -398 Thousand USD | -1755939.264% |
| Century Therapeutics, Inc. | -10.8 Million USD | -64559.416% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -677132.197% |
| Kura Oncology, Inc. | -849 Thousand USD | -823108.041% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -4160040.637% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 11383.741% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -463889.778% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -1077699.855% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -23874451.718% |
| HCW Biologics Inc. | -574.82 Thousand USD | -1215756.727% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -7108.908% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -2232818.936% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 7498.859% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -3997221.18% |
| Histogen Inc. | 3.76 Million USD | 185534.764% |
| Surrozen, Inc. | -27.23 Million USD | -25566.677% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -1868626.275% |
| Kodiak Sciences Inc. | -25.94 Million USD | -26835.816% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -53116150.722% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -10410941.501% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -341829.367% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 1092136.917% |
| Moderna, Inc. | 2.15 Billion USD | 424.317% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 997.741% |
| Turnstone Biologics Corp. | 16.5 Million USD | 42442.398% |
| Immix Biopharma, Inc. | -5468.00 USD | -127816949.561% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -13703892.686% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 4431.197% |
| Exelixis, Inc. | 1.75 Billion USD | 497.633% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -112227.809% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 6813.836% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Alkermes plc | 1.37 Billion USD | 608.412% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -630679.447% |
| Arcellx, Inc. | 108.27 Million USD | 6554.655% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -5898268.88% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 95604.719% |
| Insmed Incorporated | 239.63 Million USD | 3016.534% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -21491.758% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 8924.095% |
| Moolec Science SA | -143.3 Thousand USD | -4876935.882% |
| RenovoRx, Inc. | - USD | Infinity% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -16415.516% |
| Geron Corporation | -123.5 Million USD | -5559.001% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 212726.598% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 159739.933% |
| Royalty Pharma plc | 1.79 Billion USD | 489.601% |
| OmniAb, Inc. | 14.66 Million USD | 47751.437% |
| Alector, Inc. | -95.05 Million USD | -7252.778% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -9871.517% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -6173.032% |
| Humacyte, Inc. | -76.55 Million USD | -9030.028% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -736228.246% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 8636.019% |
| 89bio, Inc. | -273 Thousand USD | -2559986.546% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Aura Biosciences, Inc. | -1.29 Million USD | -539593.92% |
| Immunic, Inc. | -111 Thousand USD | -6296329.072% |
| Veracyte, Inc. | 248.14 Million USD | 2916.479% |
| Genelux Corporation | -848 Thousand USD | -824078.805% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -5682043.309% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -1239190728.014% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -59804.904% |
| Immunovant, Inc. | -231 Thousand USD | -3025456.827% |
| Vericel Corporation | 135.57 Million USD | 5255.069% |
| Fortrea Holdings Inc. | 424 Million USD | 1748.358% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -8011.036% |
| XBiotech Inc. | -1.74 Million USD | -400647.493% |
| Agenus Inc. | 139.61 Million USD | 5105.935% |
| Acasti Pharma Inc. | -11 Thousand USD | -63536593.364% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -173452.82% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -3415567.452% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -1077699.855% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 41693.979% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -13977.459% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -61619.655% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -1834292.722% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -31687.13% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 10358.985% |
| United Therapeutics Corporation | 2.07 Billion USD | 437.635% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 129426697.593% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -8462944.779% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 10547359.855% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -177194.55% |
| Pharming Group N.V. | 220.1 Million USD | 3275.334% |
| XOMA Corporation | 3.86 Million USD | 181116.22% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bionomics Limited | -434.44 Thousand USD | -1608612.707% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -650648.256% |
| Pyxis Oncology, Inc. | -2 Million USD | -349351.814% |
| uniQure N.V. | 2.21 Million USD | 315632.112% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -367744.014% |
| Cassava Sciences, Inc. | -89.42 Million USD | -7715.703% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -3162689.01% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -8523114.963% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -7491.085% |
| Pluri Inc. | 322 Thousand USD | 2170608.158% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| MeiraGTx Holdings plc | 287 Thousand USD | 2435304.275% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 11303.61% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -66813.021% |
| CalciMedica, Inc. | -58 Thousand USD | -12049962.534% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -22543.889% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 2030.513% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -69535630.475% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -650648.256% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 251904.08% |
| Nutriband Inc. | 862.1 Thousand USD | 810794.32% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -2049470.754% |
| Compugen Ltd. | 31.45 Million USD | 22319.158% |
| Roivant Sciences Ltd. | 109.23 Million USD | 6498.166% |
| ProKidney Corp. | -3.16 Million USD | -220443.902% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -24767907.194% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 616102.069% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -8783.879% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -5735246.811% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 28608.061% |
| Benitec Biopharma Inc. | 108 Thousand USD | 6471429.88% |
| GeoVax Labs, Inc. | -20.72 Million USD | -33629.623% |
| Biomea Fusion, Inc. | -4.2 Million USD | -166266.015% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -2254427.829% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -9051.187% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 3369.954% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -30423.808% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -8960202.91% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -742624.365% |
| Imunon, Inc. | -720 Thousand USD | -970592.741% |
| BioAtla, Inc. | -103.73 Million USD | -6637.654% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | -2778.291% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -2247178.543% |
| Zura Bio Limited | - USD | Infinity% |
| aTyr Pharma, Inc. | -2.38 Million USD | -292573.211% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -1326092.841% |
| Viridian Therapeutics, Inc. | -1 Million USD | -693256.773% |
| Galecto, Inc. | -830 Thousand USD | -841952.563% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 1197.366% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 624678.755% |
| PolyPid Ltd. | -1.82 Million USD | -383491.453% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -5873039.723% |
| Forte Biosciences, Inc. | -9000.00 USD | -77655858.556% |
| Xencor, Inc. | -85.26 Million USD | -8097.321% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -697940.849% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 3589596.205% |
| Instil Bio, Inc. | -4.75 Million USD | -146851.982% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -7391403.643% |
| OncoCyte Corporation | 413 Thousand USD | 1692360.598% |
| Elevation Oncology, Inc. | -39 Thousand USD | -17920505.821% |
| Purple Biotech Ltd. | -196 Thousand USD | -3565734.832% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 78033.054% |
| MacroGenics, Inc. | 50.52 Million USD | 13932.28% |
| Verona Pharma plc | -679.62 Thousand USD | -1028268.079% |
| Tharimmune, Inc. | - USD | Infinity% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -3993635.011% |
| Aditxt, Inc. | -111.66 Thousand USD | -6259112.135% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Savara Inc. | -44.26 Million USD | -15690.15% |
| Curis, Inc. | 9.81 Million USD | 71336.737% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -5600627.85% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -3065266.785% |
| BeiGene, Ltd. | 2.07 Billion USD | 436.196% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -24767907.194% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -763729.101% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -146205.972% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -1303824.677% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 6466.866% |
| Adicet Bio, Inc. | -6.09 Million USD | -114511.943% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 1432279.564% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Generation Bio Co. | -73.91 Million USD | -9356.016% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -1599221.801% |
| Invivyd, Inc. | -2.02 Million USD | -344527.035% |
| Relay Therapeutics, Inc. | -300.84 Million USD | -2223.166% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -6756639.564% |
| Moolec Science SA | -143.3 Thousand USD | -4876935.882% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 88894.769% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -139780625.4% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -835909.123% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 8478.632% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 9559455.879% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 13246.677% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -1979796.96% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -35379.142% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -707292.335% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -12404564.85% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 32539.249% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 2328.135% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -2393405.572% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -1052465.703% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 174259.887% |
| ImmunityBio, Inc. | -17.89 Million USD | -38966.72% |
| Korro Bio, Inc. | -3.63 Million USD | -192435.434% |
| Kineta, Inc. | 5.43 Million USD | 128740.461% |
| BioVie Inc. | -229.37 Thousand USD | -3046864.722% |
| Codexis, Inc. | 57.33 Million USD | 12290.038% |
| Celularity Inc. | 6.75 Million USD | 103564.638% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 13815154.892% |
| Cibus, Inc. | 1.42 Million USD | 491593.409% |
| Annexon, Inc. | -3.26 Million USD | -213828.26% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -16645.421% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 4140.956% |
| NeurAxis, Inc. | 2.15 Million USD | 324160.987% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -32941.964% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -369690.279% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 3020544.3% |
| Notable Labs, Ltd. | 113 Thousand USD | 6185087.85% |
| IN8bio, Inc. | -2.5 Million USD | -279349.671% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -23296687.567% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 375451.035% |
| Lumos Pharma, Inc. | 2 Million USD | 348332.998% |
| Liquidia Corporation | 14.6 Million USD | 47970.111% |
| Mustang Bio, Inc. | -2.22 Million USD | -314013.99% |
| Quantum-Si incorporated | 488 Thousand USD | 1432279.564% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -12479.485% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -3993635.011% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -34782.393% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -6613608.323% |
| Vaxcyte, Inc. | -75 Million USD | -9218.715% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -4072.26% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -580867.271% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 22176.158% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -356847.716% |
| PepGen Inc. | -1.18 Million USD | -590190.226% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -5503078.165% |
| Solid Biosciences Inc. | -76.56 Million USD | -9028.478% |
| Palisade Bio, Inc. | 246 Thousand USD | 2841171.654% |
| Nutriband Inc. | 862.1 Thousand USD | 810794.32% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | -914530.115% |
| Belite Bio, Inc | -399 Thousand USD | -1751538.163% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -15244.332% |
| GeoVax Labs, Inc. | -20.72 Million USD | -33629.623% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -21178797.788% |
| Altimmune, Inc. | -65.37 Million USD | -10591.014% |
| Peak Bio, Inc. | 367.76 Thousand USD | 1900487.545% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -1599221.801% |
| Neurogene Inc. | -3.26 Million USD | -214156.17% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 5115.995% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -12707238.673% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -189202.174% |
| Sesen Bio, Inc. | 40 Million USD | 17572.591% |
| argenx SE | 1.1 Billion USD | 730.506% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -580867.271% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 282942.423% |
| Immunome, Inc. | -8.9 Million USD | -78366.782% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -1712773.139% |
| Design Therapeutics, Inc. | -537 Thousand USD | -1301396.512% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 325777.366% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -2353110.865% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -72961.22% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 49738.042% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -261511.942% |
| Athira Pharma, Inc. | -969 Thousand USD | -721162.773% |
| XOMA Corporation | 3.86 Million USD | 181116.22% |
| Merus N.V. | -83.46 Million USD | -8274.013% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -2170408.158% |
| Rezolute, Inc. | -36 Thousand USD | -19413889.639% |
| Clene Inc. | 533 Thousand USD | 1311363.841% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -544317366.511% |
| BeyondSpring Inc. | 1.75 Million USD | 399245.418% |
| Synlogic, Inc. | -1.92 Million USD | -363155.523% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -18889187.216% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -110276.441% |
| Peak Bio, Inc. | 367.76 Thousand USD | 1900487.545% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -36756.174% |
| Krystal Biotech, Inc. | 47.6 Million USD | 14781.307% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 5053.566% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 139185.299% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -269828.356% |
| MannKind Corporation | 136.19 Million USD | 5231.79% |
| Ikena Oncology, Inc. | -50.49 Million USD | -13741.869% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 6522.92% |
| Gossamer Bio, Inc. | -4.38 Million USD | -159285.092% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -2773327.091% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -139780625.4% |
| Legend Biotech Corporation | 140.92 Million USD | 5059.261% |
| Mural Oncology plc | -2.56 Million USD | -272164.755% |
| Disc Medicine, Inc. | -100 Thousand USD | -6988936.27% |
| Champions Oncology, Inc. | 20.75 Million USD | 33775.611% |
| REGENXBIO Inc. | 53.02 Million USD | 13279.649% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -130366.634% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -3632927.301% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -403424.034% |
| Vaxart, Inc. | -60.76 Million USD | -11402.125% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -2659553.044% |
| Cellectis S.A. | 18 Thousand USD | 38828079.278% |
| Longeveron Inc. | 221 Thousand USD | 3162559.851% |
| Repare Therapeutics Inc. | -80.07 Million USD | -8628.658% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 739.44% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -540010.995% |
| Revolution Medicines, Inc. | -399.66 Million USD | -1648.728% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -19968575.057% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 14263439.327% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 181.202% |
| Denali Therapeutics Inc. | -93.34 Million USD | -7387.317% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -27901358.222% |
| Veru Inc. | 7.56 Million USD | 92475.136% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -4628400.841% |
| Cingulate Inc. | -582.91 Thousand USD | -1198874.173% |
| Passage Bio, Inc. | -3.72 Million USD | -187726.828% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -58029095.201% |
| Exicure, Inc. | -1.42 Million USD | -491048.016% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -1824713.648% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 258665.9% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -1363148.895% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -4671497.098% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -11704.608% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 1787577.307% |
| OmniAb, Inc. | 14.66 Million USD | 47751.437% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 35057.416% |
| Lipocine Inc. | -2.85 Million USD | -245058.978% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -379120.633% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -122407.209% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -463889.778% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 9379.617% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -10752263.492% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 8391.065% |
| Ocugen, Inc. | -33.53 Million USD | -20739.778% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -220932.14% |
| Q32 Bio Inc. | 578 Thousand USD | 1209275.825% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -2637272.177% |
| Alumis Inc. Common Stock | -1.28 Million USD | -544217.467% |
| Equillium, Inc. | 35.95 Million USD | 19536.666% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -409333.876% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 1396011.606% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -169062219.061% |
| Dominari Holdings Inc. | 2.03 Million USD | 342867.841% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -3809241.133% |
| vTv Therapeutics Inc. | -13.59 Million USD | -51308.873% |
| Bio-Techne Corporation | 773.07 Million USD | 1004.058% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 40454.733% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 1616.764% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -597764.523% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -29045.272% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 59850.673% |
| Nkarta, Inc. | -5.86 Million USD | -118983.937% |
| BioCardia, Inc. | -7.24 Million USD | -96313.799% |
| Iterum Therapeutics plc | -1.75 Million USD | -399273.501% |